The price of GLP-1 drugs has attracted the scrutiny of lawmakers, and Novo Nordisk's chief executive Lars Fruergaard Jrgensen has agreed to appear at a Senate hearing next week to defend the pricing of the group's semaglutide-based therapies
As more people use semaglutide, reports of unexpected side effects are growing: unpleasant changes to your skin and body shape, digestive problems, and unexpected fatigue (sometimes called GLP-1 fatigue.) I want to make you aware of these potential problems so you aren't caught off-guard and left holding your stomach and your head...and wondering why you suddenly look old and feel so tired if you opt for a GLP-1 drug
The gold standard
When this refinery is stressed or clogged with fat, it loses the ability to maintain quality control, releasing high-risk particles that trigger a cascade of inflammation and metabolic instability
Micro-dosing refers to using significantly smaller amounts of GLP-1 medication
Soleiman applies decades of clinical decision-making to laboratory interpretation, side-effect management, and riskbenefit counseling for GLP1based therapies
